Cian Healthcare Complete Financial Statements
CHCL • Review detailed financials to uncover trends, confirm thesis & journal trades
6 Years of Data
2025 - 2020
Complete Financial Data Export
Export complete financial statements for Cian Healthcare (CHCL).
Downloads include all available records across all periods.
For market performance, see the
CHCL stock price today
.
Profitability Ratios
Net Profit Margin
-83.87%
2025 data
EBITDA Margin
-19.35%
2025 data
Operating Margin
-22.00%
2025 data
Return on Assets
-16.67%
2025 data
Return on Equity
-81.25%
2025 data
Balance Sheet Ratios
Current Ratio
7.89
2025 data
Debt to Equity
4.88
2025 data
Equity Ratio
20.51%
2025 data
Asset Turnover
0.20
2025 data
Year-over-Year Growth Analysis
Comparing March 2025 vs Period
Revenue Growth
-100.0%
Year-over-Year
Net Profit Growth
+100.0%
Year-over-Year
EBITDA Growth
+100.0%
Year-over-Year
Expense Growth
-100.0%
Year-over-Year
Assets Growth
-3.1%
Year-over-Year
Equity Growth
-44.8%
Year-over-Year
Liabilities Growth
-3.1%
Year-over-Year
Operating Cash Flow Growth
+75.0%
Year-over-Year
Investing Cash Flow Growth
+100.0%
Year-over-Year
Financing Cash Flow Growth
+60.0%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | None | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | 0 | 31 | 62 | 69 | 78 | 74 | 58 |
| Expenses | 0 | 38 | 51 | 56 | 74 | 62 | 50 |
| EBITDA | 0 | -6 | 11 | 13 | 5 | 12 | 8 |
| Operating Profit Margin % | 0.00% | -22.00% | 18.00% | 18.00% | 5.00% | 16.00% | 13.00% |
| Depreciation | 0 | 4 | 6 | 5 | 4 | 4 | 4 |
| Interest | 0 | 3 | 6 | 6 | 6 | 8 | 7 |
| Profit Before Tax | 0 | -26 | 0 | 2 | -6 | 1 | -4 |
| Tax | 0 | 0 | -1 | 0 | -1 | 1 | 0 |
| Net Profit | 0 | -26 | 1 | 2 | -6 | 0 | -4 |
| Earnings Per Share (₹) | 0.00 | -10.39 | 0.34 | 0.81 | -2.21 | 0.02 | -1.62 |
Related Pages for Cian Healthcare
Additional stock information and data for CHCL
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Total Assets | 156 | 161 | 161 | 166 | 157 | 157 |
| Current Assets | 71 | 72 | 74 | 79 | 63 | 54 |
| Fixed Assets | 35 | 39 | 45 | 50 | 37 | 39 |
| Capital Work in Progress | 15 | 15 | 14 | 13 | 26 | 25 |
| Investments | 0 | 0 | 0 | 0 | 0 | 5 |
| Other Assets | 106 | 107 | 102 | 103 | 95 | 87 |
| LIABILITIES | ||||||
| Total Liabilities | 156 | 161 | 161 | 166 | 157 | 157 |
| Current Liabilities | 9 | 37 | 38 | 41 | 41 | 50 |
| Non-Current Liabilities | ||||||
| SHAREHOLDERS' EQUITY | ||||||
| Total Equity | 32 | 58 | 58 | 56 | 58 | 58 |
| Share Capital | 25 | 25 | 25 | 25 | 23 | 23 |
| Reserves & Surplus | 7 | 33 | 33 | 31 | 35 | 35 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 |
|---|---|---|---|---|---|---|
| Operating Activities | 21 | 12 | 5 | 9 | 6 | -7 |
| Investing Activities | 0 | -2 | 3 | 1 | 3 | -27 |
| Financing Activities | -4 | -10 | -7 | -11 | -10 | 36 |
| Net Cash Flow | 17 | 0 | 0 | -1 | -1 | 1 |